When the COVID-19 Omicron variant broke out in January 2022, testing needs skyrocketed in a matter of weeks. Germany-based medical technology company Siemens Healthineers stepped up to make tens of millions of rapid antigen self-tests available to the U.S. population through state, federal, and local partnership efforts.
Read: Biotech Co. Outfits Nine COVID-19 Test Kit Lines with New Labelers
